BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics

Award Date 9/7/2018
Last Date To Order 9/5/2023
Shared Ceiling $75M
Contract Type
Master IDIQ
Predecessor
Not listed
Successors

The BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics is a master indefinite delivery/indefinite quantity (IDIQ) contract vehicle awarded by the Food and Drug Administration's Center for Biologics Evaluation and Research (CBER). The primary objective of this contract is to expand and enhance CBER's capabilities in data sources, infrastructure, methods, and tools for conducting surveillance and epidemiological studies related to biologic products. The vehicle focuses on assuring the safety and effectiveness of biologics, including vaccines, blood and blood products, tissues, and advanced therapeutics, by providing comprehensive data analytics and research support.

The task orders under this IDIQ are predominantly time and materials contracts, with values ranging from approximately $2.7 million to $25.7 million and typical durations of one to three years. Key prime contractors include Acumen LLC (doing business as Medric), International Business Machines Corporation (IBM), and IQVIA Government Solutions Inc. All task orders to date have been awarded by the Department of Health and Human Services Food and Drug Administration, with no specific small business set-aside designations. Performance locations include Burlingame, California; Westlake, Maryland; and potentially other locations. The task orders consistently involve developing data infrastructure, conducting surveillance activities, and supporting post-market monitoring of biologic products, with a recent emphasis on COVID-19 related biologics surveillance.

Generated 1/16/25, 12:18 AM